A Study of AL58805 in Patients With Advanced Tumors

NCT07179081 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Tumors

Interventions

DRUG: AL58805

Sponsor

Advenchen Laboratories Nanjing Ltd.